The University of Chicago Header Logo

Connection

Dejan Micic to Male

This is a "connection" page, showing publications Dejan Micic has written about Male.
Connection Strength

2.558
  1. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis. Nutr Clin Pract. 2024 Jun; 39(3):634-640.
    View in: PubMed
    Score: 0.244
  2. Predictive Model for Positive Video Capsule Endoscopy in Iron Deficiency Anemia. Dig Dis Sci. 2023 07; 68(7):3083-3091.
    View in: PubMed
    Score: 0.227
  3. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1620-1625.
    View in: PubMed
    Score: 0.206
  4. Impact of Early Video Capsule Endoscopy on Hospitalization and Post-hospitalization Outcomes: A Propensity Score-Matching Analysis. Dig Dis Sci. 2022 08; 67(8):3584-3591.
    View in: PubMed
    Score: 0.204
  5. Getting to the Root of the Problem. Gastroenterology. 2020 04; 158(5):1229-1231.
    View in: PubMed
    Score: 0.179
  6. Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy. PLoS One. 2019; 14(2):e0212509.
    View in: PubMed
    Score: 0.171
  7. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024.
    View in: PubMed
    Score: 0.160
  8. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900.
    View in: PubMed
    Score: 0.155
  9. Factors associated with long-term clinical outcome in microscopic colitis. Ann Med. 2024 Dec; 56(1):2365989.
    View in: PubMed
    Score: 0.062
  10. Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer. J Clin Gastroenterol. 2023 09 01; 57(8):804-809.
    View in: PubMed
    Score: 0.059
  11. TGR5 signaling mitigates parenteral nutrition-associated liver disease. Am J Physiol Gastrointest Liver Physiol. 2020 02 01; 318(2):G322-G335.
    View in: PubMed
    Score: 0.046
  12. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
    View in: PubMed
    Score: 0.044
  13. Risk Factors for 30-day Hospital Readmission for Diverticular Hemorrhage. J Clin Gastroenterol. 2019 04; 53(4):e133-e141.
    View in: PubMed
    Score: 0.043
  14. Risk of Colorectal Cancer in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2018 10; 52(9):796-804.
    View in: PubMed
    Score: 0.042
  15. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493.
    View in: PubMed
    Score: 0.041
  16. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 06; 19(6):758-767.
    View in: PubMed
    Score: 0.040
  17. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
    View in: PubMed
    Score: 0.040
  18. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
    View in: PubMed
    Score: 0.040
  19. Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
    View in: PubMed
    Score: 0.039
  20. Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017 Aug 11; 2017.
    View in: PubMed
    Score: 0.039
  21. Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-a agent (infliximab), in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 04; 45(8):1043-1057.
    View in: PubMed
    Score: 0.037
  22. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis. 2016 Dec; 10(12):1385-1394.
    View in: PubMed
    Score: 0.036
  23. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
    View in: PubMed
    Score: 0.035
  24. Hematochezia and a Mesenteric Mass. Gastroenterology. 2015 Jul; 149(1):e12-3.
    View in: PubMed
    Score: 0.033
  25. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15; 61(2):233-41.
    View in: PubMed
    Score: 0.033
  26. In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease. J Crohns Colitis. 2014 Nov; 8(11):1539-47.
    View in: PubMed
    Score: 0.031
  27. Challenges in the diagnosis of Clostridium difficile infection. Gastroenterology. 2014 Jun; 146(7):1820-2.
    View in: PubMed
    Score: 0.031
  28. The systemic inflammatory response to Clostridium difficile infection. PLoS One. 2014; 9(3):e92578.
    View in: PubMed
    Score: 0.030
  29. Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS One. 2014; 9(2):e89332.
    View in: PubMed
    Score: 0.030
  30. Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults. J Am Geriatr Soc. 2013 Oct; 61(10):1738-42.
    View in: PubMed
    Score: 0.029
  31. Understanding increased mortality in Clostridium difficile-infected older adults. Clin Infect Dis. 2013 Aug; 57(4):625-6.
    View in: PubMed
    Score: 0.029
  32. Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One. 2013; 8(3):e58265.
    View in: PubMed
    Score: 0.028
  33. Reply to Walker et al. Clin Infect Dis. 2013 Jun; 56(12):1846-7.
    View in: PubMed
    Score: 0.028
  34. Reply to McDonald. Clin Infect Dis. 2013 Mar; 56(6):907-8.
    View in: PubMed
    Score: 0.028
  35. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012 Dec; 55(12):1661-8.
    View in: PubMed
    Score: 0.027
  36. [Diverticulosis of the digestive tract in our patients over a 10-year period]. Zb Vojnomed Akad. 1981; 23:42-5.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.